Organicell Regenerative Medicine Is A Clinical Stage Biopharmaceutical Company Based In South Floridafocusing On Regenerative Medicine And Exosome Based Therapeuticsthe Company Is Fully Integratedwith Expertise In Researchnanotechnologymanufacturingand Clinical Developmentorganicell Is Listed On The Otcqb Market Under The Ticker Symbol Ocel And Is Dedicated To Developing Biologic Therapies For Chronic Diseases And Degenerative Conditions The Company Specializes In Proprietary Biologic Therapies That Utilize Perinatal Derived Exosomeshyaluronic Acidand Proteinsprocessed To Maintain Their Bioactive Propertiesorganicell Emphasizes Innovation In Exosome Technologyleveraging Nanoparticles For Tissue Repair And Anti Inflammatory Effectsits Regenerative Medicine Solutions Target Conditions Such As Osteoarthritispulmonary Disordersand Age Related Degenerative Diseasesorganicell Aims To Transform Healthcare By Integrating Exosome Technology With Synergistic Therapiespositioning Itself As A Biologic Medicine Incubator
No conferences found for this company.
| Company Name | Organicell Regenerative Medicine Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
